Danielsen appointed Visiting Professor at University of Oxford
The University of Oxford's Medical Sciences Board has conferred on Håvard Danielsen the title of Visiting Professor of Cancer Informatics in recognition of his important contributions towards the successful and fruitful collaboration with their University.
The University of Oxford is a partner in the DoMore! project,, and Institute Director, Håvard E. Danielsen, also serves as chair of the panel of expertise in the Colorectal Cancer Research Collaboration Network ( crcnetwork.net),. The network includes representatives from some of the highest-ranked universities in Europe, the University of Oxford being among them.
Op-ed in "DN"
An op-ed authored by Elin Ersvær and Karolina Cyll, both PhD Candidates at the ICGI, and Institute Director Håvard E. Danielsen was published in "Dagens Næringsliv" (DN) 30th September. The Norwegian newspaper specializes in business news, and is the third largest newspaper in Norway. As part of their general coverage of health care businesses, big data and (cancer) research, DN has shown a keen interest in our Domore! project.
The institute's DoMore!-project makes computers understand how tumours evolve and what kind of treatment is needed, and the op-ed explains why present methods are insufficient. Click the image to read the article.
On Tuesday 19th September 2017, Andreas Kleppe defended his dissertation for the degree of Ph.D. at the Institute for Informatics at the University of Oslo. Colleagues and family were greatly impressed by the young Doctor who will continue his work at our Institute.
The trial lecture was entitled "Challenges and opportunities in digital pathology of tomorrow regarding multimodal data collection, machine learning and validation”. The topic of the dissertation was:
"Automatic detection of aberrant chromatin structure predicts prognosis in several cancer types".
Congratulations Dr. Kleppe!
Better knowledge base for treatment of endometrial cancer
Manohar Pradhan is a pathologist and one of our many great researchers. He has recently published a paper in Gynecologic Oncology, in collaboration with colleagues from the ICGI, the University of British Columbia and the University of Oxford. The findings reported will contribute to a better knowledge base for the choice of treatment for women with endometrial cancer.
Please find the article here: Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer.
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). Endometrial cancer is sometimes loosely referred to as "uterine cancer", although it is distinct from other forms of uterine cancer such as cervical cancer, uterine sarcoma, and trophoblastic disease. The most frequent type of endometrial cancer is endometrioid carcinoma, which accounts for more than 80% of cases. Endometrial cancer is commonly diagnosed by endometrial biopsy or by taking samples during a procedure known as dilation and curettage. Though the five-year-survival rate after being diagnosed with endometrial cancer is >90%, this cancer type is the third most common cause of death in cancers which only affect women.
Doing More in Prognosis and Diagnosis
The ICGI is part of Oslo Cancer Cluster. Their story about ICGl, DoMore! and the significance of new technology development in the fight against cancer was published on their website during the summer of 2017.
Please click here to read the full article.
Prof. Håvard Danielsen appointed Scientist of the Month by The South-Eastern Norway Regional Health Authority for the month of June 2017
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of June 2017, this honour went to professor Håvard Danielsen, head of the Institute for Cancer Genetics and Informatics at Oslo University Hospital.
Read the article Lager en ny verden av analysemuligheter from the web pages of OUH (in Norwegian only).
CCC accreditation for OUH
We are so proud to be able to tell that The European Cancer Institute has given Oslo University Hospital (OUS) status as a Comprehensive Cancer Center (CCC). Accreditation is provided for the hospital's total cancer activity and includes all clinics and departments involved in the diagnosis and treatment of cancer. The ICGI has participated in groups, teams and boards at Oslo University Hospital who through tedious work, over a long period of time, have made this possible.
About the DoMore! project in Science Nordic
An article about our research project DoMore! is now published in English, on the Science Nordic website. This is following recent articles in norwegian which may be found on our norwegian newsroom "myNewsDewsk".
View our strategy document online
We have recently completed the presentation folder containing the Institute's strategy for the next five years. This is a document we are proud of, where both text and images present our diversity, strengths and focus areas.
Please contact us or drop by if you would like a paper copy.
The pdf of the document may be viewed online by clickinghere.
Third CRC Network meeting
The CRC Network is an international network of researchers aiming to improve diagnosis, research and medical treatment of colon- and rectum cancer with emphasis on increased understanding of genetic mechanisms.
The inaugural of the Oxford Centre for Cancer Gene Research at the University of Oxford, and the third meeting for the CRC Network will take place in the historic settings of the Queen's College on the 30th and 31st March 2017.
Specially invited speakers, among them some of the world's finest researchers, will present their latest achievements and research on colorectal cancer. This year's theme is Genome Stability and Instability in Cancer.
The lecture session is open to all interested in advances within research on colorectal cancer, and the event is now fully booked. Go to www.crcnetwork.net to read more about the CRC Network.